By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Can Thinking Younger Make You Live Longer?
    April 20, 2011
    Image
    Obesity’s Outlook Unchanged
    June 13, 2011
    When It’s An Emergency Elderly Not Treated As Well in Hospitals
    July 16, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: A Theory on Why The FDA Hid Conflicts of Interest
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > A Theory on Why The FDA Hid Conflicts of Interest
BusinessMedical Ethics

A Theory on Why The FDA Hid Conflicts of Interest

gooznews
Last updated: January 15, 2012 10:12 am
gooznews
Share
7 Min Read
SHARE

Much has been made of Health and Human Services Secretary Kathleen Sebelius’ decision last month to overrule Food and Drug Administration scientists and prohibit the over-the-counter sale of the morning after pillto minors. Many observers blasted the move as a blatant political move by the White House, which didn’t want to antagonize social conservatives ahead of this year’s election.

Much has been made of Health and Human Services Secretary Kathleen Sebelius’ decision last month to overrule Food and Drug Administration scientists and prohibit the over-the-counter sale of the morning after pillto minors. Many observers blasted the move as a blatant political move by the White House, which didn’t want to antagonize social conservatives ahead of this year’s election.

Now there is the possibility politicians on Capitol Hill are also influencing some choices being made at the FDA. It involves the agency’s decision last month to appoint at least three scientists to a high-profile drug safety advisory committee without disclosing they had conflicts of interest with the company – Bayer – whose product – birth control pills – was up for review.

The committee recommended that Bayer be allowed to keep its problematic birth control pills – sold as Yaz and Yasmin – on the market even though the agency’s adverse events reporting system had turned up dozens of deaths from blood clots. Thousands of lawsuits have been filed against the company alleging the pills damaged women’s health. Still, the committee said the benefits of having another birth control option on the market outweighed the risks.

More Read

Left to Our Own Devices
Who Owns Frozen Embryos?
A Slice of Geek Heaven at FutureMed 2013 in San Diego
Medical Tricorders Fit for Dr. McCoy: XPRIZE Contestants
What can we do about overuse of emergency rooms?

The vote was close – 15-11 – and dogged by controversy. Before the meeting, the FDA ruled that the safety committee’s usual consumer representative, Dr. Sidney Wolfe from Public Citizen, a long-time thorn in industry’s side, couldn’t participate because his newsletter, “Worst Pills, Best Pills,” had already called for banning the drugs. In addition, the agency refused to distribute a long legal and scientific brief prepared for plaintiffs’ attorneys by Dr. David Kessler, who once headed the agency. He submitted it too late, the agency ruled.

The latest scandal was turned up by investigative reporters for the British Medical Journal, where many of the studies outlining the risks from birth control pills first appeared. Their report, which appeared earlier this week in the Washington Monthly, revealed that at least three obstetricians/gynecologists on the committee had financial ties to Bayer. Not only that, the FDA knew about the financial conflicts of interest and didn’t tell the public.

The Wall Street Journal on Wednesday followed up with some juicy details about the ties between some of the researchers and Bayer. For instance, Dr. Paula Hillard, an obstetrics professor at Stanford University School of Medicine, attended two meetings sponsored by the company in 2010 to help it deal with the blood clot controversy, and was paid “less than $10,000” for her efforts, the paper reported. She, like the others named in the Monthly article, voted to keep the pills on the market.

So where does Capitol Hill come in? Last October, Senators Michael Bennet (D-Co.), Richard Burr (R-N.C.), and Amy Klobuchar (D-Minn.) introduced legislation that would loosen the FDA’s conflict of interest policies. The ostensible goal? To speed up the review of medical products. That legislation followed statements by FDA Commission Margaret Hamburg that the agency was having difficulties finding people without conflicts of interest to serve on its 55 committees.

The FDA, like every federal agency, is forbidden from appointing scientists with conflicts of interest to its technical advisory committees. However, the law allows exceptions. If the agency needs that particular person’s expertise, it can grant a waiver as long as it is disclosed to the public. It can also waive the conflict if it is considered too minor to actually affect a person’s judgment. Unfortunately, the law does not specify what is considered “de minimus.” $50,000? $5,000? $500?

Time for some personal disclosure: I spent five years during the 2000s as a public interest advocate lobbying to ban the use of scientists with conflicts of interest on federal advisory committees. It never passed Congress, but in 2007 the reauthorization of the Prescription Drug User Fee Act included a section that limited the total number of waivers allowed by the FDA.

My reasoning, like the many consumer organizations which backed a total ban on using conflicted scientists, was that there are plenty of non-conflicted experts at American universities, research institutes or in private practice who are just as knowledgeable as people who sign consulting deals with industry. Moreover, eliminating the whiff of impropriety that appointing scientists with conflicts of interest brings would maintain the public’s faith in the integrity of the process, even if the appointee swears up and down that is or she isn’t biased by the relationship.

The fact the FDA didn’t even disclose through the waiver process that those ties existed was deeply troubling to many observers. “Lack of disclosure undermines the credibility of the advisory committee process and undermines public trust in the fairness of the regulatory process,” Dr. Steven Nissen, a cardiologist at the Cleveland Clinic, told the Journal. The process is further undermined if the agency skirts its own rules to placate critics on Capitol Hill.

TAGGED:conflict of interestFDA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

mammogram cost
BusinessFinance

What Do California Insurers Pay for Mammograms? $134.41 or $1200

July 9, 2014

Online Conversion Optimization Strategies for Healthcare Professionals

February 19, 2016

Do Appointment Reminders Work?

November 25, 2011
clinical trials
Business

Top 3 Reasons People Participate in Clinical Trials

October 20, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?